Biogen (HAM:IDP) Days Sales Outstanding

: 76.39 (As of Dec. 2022)

View and export this data going back to 2001. Start your Free Trial

Biogen's average Accounts Receivable for the three months ended in Dec. 2022 was €2,010 Mil. Biogen's Revenue for the three months ended in Dec. 2022 was €2,402 Mil. Hence, Biogen's Days Sales Outstanding for the three months ended in Dec. 2022 was 76.39.

The historical rank and industry rank for Biogen's Days Sales Outstanding or its related term are showing as below:

HAM:IDP' s Days Sales Outstanding Range Over the Past 10 Years
Min: 39.79 Med: 61.65 Max: 73.52
Current: 72.52

During the past 13 years, Biogen's highest Days Sales Outstanding was 73.52. The lowest was 39.79. And the median was 61.65.

HAM:IDP's Days Sales Outstanding is ranked worse than
53.78% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 69.80 vs HAM:IDP: 72.52

Biogen's Days Sales Outstanding increased from Dec. 2021 (66.77) to Dec. 2022 (76.39).

Biogen Days Sales Outstanding Historical Data

The historical data trend for Biogen's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogen Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

63.97

62.17

68.31

68.52

71.32

Biogen Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Days Sales Outstanding																66.77	70.88	69.50	70.22	76.39

Competitive Comparison

For the Drug Manufacturers - General subindustry, Biogen's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

Biogen Days Sales Outstanding Distribution

For the Drug Manufacturers industry and Healthcare sector, Biogen's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Biogen's Days Sales Outstanding falls in comparison to its industry or sector. The grey bar indicates the Days Sales Outstanding's extreme value range as defined by GuruFocus.

Biogen Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Biogen's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (1736.1045000382	+	2016.7615999968)	/	2 )	/	9603.6895999846	*	365
=	1876.4330500175					/	9603.6895999846	*	365
=	71.32

Biogen's Days Sales Outstanding for the quarter that ended in Dec. 2022 is calculated as:

	Days Sales Outstanding (Q: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2022 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (2004.042000002	+	2016.7615999968)	/	2 )	/	2401.5359999962	*	365 / 4
=	2010.4017999994					/	2401.5359999962	*	365 / 4
=	76.39

Biogen (HAM:IDP) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Biogen Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Biogen's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Biogen (HAM:IDP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biogen Inc (HAM:IDP) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

BIIB:USA BIIB:Mexico IDP:Germany BIIB34:Brazil BIIB:Austria BIIB:Argentina

Address

225 Binney Street, Cambridge, MA, USA, 02142

Website

http://www.biogen.com

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021, followed by Leqembi in January 2023.

Biogen (HAM:IDP) Headlines

No Headlines